COVID-19 vaccination unveiling subclinical Sjögren's syndrome.

Ramos-Casals, Manuel; Sainz-de-la-Maza, Maite; Muxí, Africa

Ramos-Casals, Manuel; Sainz-de-la-Maza, Maite; Muxí, Africa.

Ramos-Casals M; Department of Autoimmune Diseases, ICMiD, Hospital Clinic, Barcelona, Spain. mramos@clinic.cat.
Sainz-de-la-Maza M; Clínic Institute of Ophthalmology, ICOF, Hospital Clinic, Barcelona, Spain.
Muxí A; Department of Nuclear Medicine, University of Barcelona, Hospital Clínic, Barcelona, Spain.

Clin Exp Rheumatol ; 39 Suppl 133(6): 228-229, 2021.

Article in English | MEDLINE | ID: covidwho-1856818

Subject(s)

COVID-19; Sjogren's Syndrome; COVID-19 Vaccines; Humans; SARS-CoV-2; Sjogren's Syndrome/diagnosis; Vaccination/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Sjogren's Syndrome / COVID-19 Type of study: Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: Clin Exp Rheumatol Year: 2021 Document Type: Article Affiliation country: CLINEXPRHEUMATOL

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google